Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:1051 (1 November), doi:10.1136/bmj.327.7422.1051
| The first 150 words of the full text of this article appear below. |
EDITORCranney's editorial thoroughly covered the pharmacological options available for treating postmenopausal osteoporosis.1 Non-pharmacological treatments may also have a role, given the uncertainties in managing osteoporosis.
Exercise is a simple intervention that can be advised for postmenopausal women with osteoporosis and is beneficial for other health issues as well. Several systematic reviews have shown an increase in bone mineral density.2
Another key issue is the need to decrease the risk of falling. Systematic reviews show the effectiveness of measures to prevent falls, and evidence shows that some available interventions are likely to be effective.3
In the last update of a review about hip protectors the initial beneficial effect observed was not confirmed from studies using individual randomisation.4 Another issue is that most trials targeted people at particularly high risk of fracture.
Head to head comparisons are required, however, and not just among pharmacological options. Results from the women's health
Pablo Alonso-Coello, research fellow
Iberoamerican Cochrane Centre, Hospital de la Santa Creu i Sant Pau, C/Sant Antoni Ma Claret, 171, E-08041 Barcelona, Spain
Merc Marzo-Castillejo, medical adviser
Mmarzo@ics.scs.es Iberoamerican Cochrane Centre, Hospital de la Santa Creu i Sant Pau, C/Sant Antoni Ma Claret, 171, E-08041 Barcelona, Spain